CAT and B-cell chronic lymphocytic leukemia: The pretreatment of B-CLL cells with a glutathione-reducing buthionine sulfoximine or catalase-inhibiting aminotriazole boosted As2O3/vitamin C-mediated cytotoxicity, indicating that this action is dependent on increased ROS buildup.